2025-05-22
Gx Inbeneo®
- new publication
Greater formulation freedom with a novel autoinjector platform that extends volume and viscosity limits. Discover how the innovative
Gx Inbeneo® autoinjector platform is pushing the boundaries of drug delivery.
In the latest issue of ONdrugDelivery, Gerresheimer and Midas Pharma showcase how this cartridge-based technology overcomes the limitations of traditional PFS-based autoinjectors - enabling the delivery of larger volumes and very high-viscosity formulations.
The article also presents test results that validate the platform’s performance and its capability to meet the demands of subcutaneous delivery of next-generation biologics.
Your Contact
Dr. Matthias Bauch
Biotechnology & Devices
Global Vice President
Midas Pharma GmbH
Rheinstraße 49
55218 Ingelheim
Germany
Rheinstraße 49
55218 Ingelheim
Germany